Evidence-based use of colony-stimulating factors in elderly cancer patients.

BACKGROUND Neutropenia and its complications represent the major dose-limiting toxicity of cancer chemotherapy, especially in the elderly. Hematopoietic growth factors have been shown to reduce the severity and duration of febrile neutropenia (FN) and to sustain chemotherapy dose intensity. METHODS A systematic review was undertaken of studies of the… CONTINUE READING